FTSE All-Share
4.428,91
PKT
-50,08
PKT
-1,12
%
Werbung
Analysen zu FTSE All-Share-Werten
Datum | Rating | Analyst | |
---|---|---|---|
18.12.24 | National Grid Buy | UBS AG | |
18.12.24 | National Grid Buy | Jefferies & Company Inc. | |
18.12.24 | Unilever Underperform | Jefferies & Company Inc. | |
18.12.24 | National Grid Outperform | RBC Capital Markets | |
18.12.24 | GSK Hold | Deutsche Bank AG | |
18.12.24 | National Grid Buy | Goldman Sachs Group Inc. | |
18.12.24 | GSK Neutral | Goldman Sachs Group Inc. | |
17.12.24 | AstraZeneca Hold | Deutsche Bank AG | |
17.12.24 | GSK Hold | Deutsche Bank AG | |
17.12.24 | London Stock Exchange (LSE) Buy | UBS AG | |
16.12.24 | BP Buy | UBS AG | |
16.12.24 | AstraZeneca Hold | Deutsche Bank AG | |
16.12.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
13.12.24 | HSBC Neutral | UBS AG | |
13.12.24 | HSBC Equal Weight | Barclays Capital | |
13.12.24 | Rio Tinto Sector Perform | RBC Capital Markets | |
12.12.24 | London Stock Exchange (LSE) Hold | Deutsche Bank AG | |
12.12.24 | BAT Buy | Deutsche Bank AG | |
12.12.24 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
12.12.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.12.24 | BAT Neutral | JP Morgan Chase & Co. | |
11.12.24 | Diageo Buy | UBS AG | |
11.12.24 | BAT Neutral | Goldman Sachs Group Inc. | |
11.12.24 | GSK Neutral | Goldman Sachs Group Inc. | |
11.12.24 | BAT Neutral | UBS AG | |
11.12.24 | BAT Sector Perform | RBC Capital Markets | |
11.12.24 | GSK Underweight | JP Morgan Chase & Co. | |
11.12.24 | BAT Neutral | JP Morgan Chase & Co. | |
10.12.24 | GSK Hold | Jefferies & Company Inc. | |
10.12.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
10.12.24 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
10.12.24 | BP Buy | Goldman Sachs Group Inc. | |
10.12.24 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
09.12.24 | BP Buy | UBS AG | |
09.12.24 | BP Buy | Jefferies & Company Inc. | |
09.12.24 | BP Sector Perform | RBC Capital Markets | |
09.12.24 | BP Underweight | JP Morgan Chase & Co. | |
09.12.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
09.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
09.12.24 | Vodafone Group Neutral | Goldman Sachs Group Inc. |